The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia
Status:
Terminated
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the long-term economic, functional and clinical
outcomes in schizophrenia patients who require a change in antipsychotic treatment, and are
changed to either paliperidone extended release (ER) or another oral atypical antipsychotic
agent (AAP) including aripiprazole, olanzapine, quetiapine, risperidone, or ziprasidone.